The Journal of Neuroscience, September 15, 1999, 19(18):7732-7741
Insulin Prohormone Processing, Distribution, and Relation to
Metabolism in Aplysia californica
Philip D.
Floyd1,
Lingjun
Li1,
Stanislav S.
Rubakhin1,
Jonathan V.
Sweedler1,
Charles C.
Horn2,
Irving
Kupfermann2,
Vera Y.
Alexeeva3,
Timothy A.
Ellis3,
Nikolai C.
Dembrow3,
Klaudiusz R.
Weiss3, and
Ferdinand S.
Vilim3
1 Department of Chemistry and the Beckman Institute,
University of Illinois, Urbana, Illinois 61801, 2 Center
for Neurobiology and Behavior, Columbia University, New York, New York
10032, and 3 Department of Physiology and Biophysics, Mount
Sinai School of Medicine, New York, New York 10029
The first Aplysia californica insulin gene is
characterized and its proteolytic processing from prohormone to final
peptides elucidated using a combination of biochemical and mass
spectrometric methods. Aplysia insulin (AI) is one of
the largest insulins found, with a molecular weight of 9146 Da, and an
extended A chain compared with other invertebrate and vertebrate
insulins. The AI prohormone produces a series of C peptides and also a
unique N-terminally acetylated D peptide. AI-producing cells are
restricted to the central region of the cerebral ganglia mostly within
the F and C clusters, and AI is transported to neurohemal release sites located on the upper labial and anterior tentacular nerves. The expression of AI mRNA decreases when the animal is deprived of food,
and injections of AI reduce hemolymph glucose levels, suggesting that
the function of insulin-regulating metabolism has been conserved.
Key words:
insulin; neuropeptide; Aplysia californica; cerebral ganglion; hunger/satiation; glucose
Copyright © 1999 Society for Neuroscience 0270-6474/99/19187732-10$05.00/0